AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 80 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $37,000 | -82.0% | 3,575 | -71.3% | 0.00% | – |
Q2 2023 | $205,000 | – | 12,460 | +6130.0% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 200 | -70.0% | 0.00% | – |
Q1 2022 | $4,000 | -42.9% | 667 | -10.3% | 0.00% | – |
Q4 2021 | $7,000 | -30.0% | 744 | -20.7% | 0.00% | – |
Q3 2021 | $10,000 | +400.0% | 938 | +122.8% | 0.00% | – |
Q2 2021 | $2,000 | -60.0% | 421 | -18.4% | 0.00% | – |
Q1 2021 | $5,000 | -16.7% | 516 | -40.6% | 0.00% | – |
Q4 2020 | $6,000 | +500.0% | 869 | -13.1% | 0.00% | – |
Q1 2019 | $1,000 | 0.0% | 1,000 | +300.0% | 0.00% | – |
Q4 2018 | $1,000 | -95.5% | 250 | -95.0% | 0.00% | – |
Q3 2018 | $22,000 | -35.3% | 5,000 | -9.6% | 0.00% | – |
Q2 2018 | $34,000 | -41.4% | 5,532 | -31.2% | 0.00% | – |
Q1 2018 | $58,000 | +18.4% | 8,038 | +33.3% | 0.00% | – |
Q4 2017 | $49,000 | -23.4% | 6,029 | +0.5% | 0.00% | – |
Q3 2017 | $64,000 | -3.0% | 6,000 | 0.0% | 0.00% | – |
Q2 2017 | $66,000 | +13.8% | 6,000 | -1.3% | 0.00% | – |
Q1 2017 | $58,000 | – | 6,077 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 1,625,000 | $12,269,000 | 3.04% |
GENDELL JEFFREY L | 1,146,764 | $8,658,000 | 1.11% |
Broadfin Capital, LLC | 1,029,012 | $7,769,000 | 1.04% |
RTW INVESTMENTS, LP | 3,401,434 | $25,681,000 | 0.97% |
BRANDES INVESTMENT PARTNERS, LP | 3,651,948 | $27,571,000 | 0.66% |
Aristides Capital LLC | 71,520 | $540,000 | 0.42% |
Tekla Capital Management LLC | 814,588 | $6,150,000 | 0.23% |
INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV | 36,100 | $273,000 | 0.17% |
Leap Investments LP | 43,481 | $328,000 | 0.15% |
Brown Capital Management | 1,829,886 | $13,816,000 | 0.13% |